Callitas Health Inc. Share Price Canadian Securities Exchange
Equities
LILY
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 1.03 62.6 | Sales 2019 | 0.71 0.97 59.18 | Capitalization | 3.53M 4.82M 294M |
---|---|---|---|---|---|
Net income 2018 | -5M -6.84M -417M | Net income 2019 | -1M -1.37M -83.46M | EV / Sales 2018 | 48,52,616 x |
Net Debt 2018 | 319K 436K 26.62M | Net Debt 2019 | 848K 1.16M 70.75M | EV / Sales 2019 | 61,68,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03/18/03 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/14/01 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+27.01% | 44.96B | |
+0.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.12% | 26.08B | |
-21.07% | 19.03B | |
+6.44% | 12.75B | |
+28.76% | 12.06B | |
-3.96% | 11.75B |